Legacy Capital Group California’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,554	Closed	-$209K	–	330
2025 Q1	$209K	Buy	9,554 +2,359	+33%	+$51.6K	0.07%	295
2024 Q4	$230K	Buy	+7,195	New	+$230K	0.07%	290